Ho Kuo-Wei, Fang Ku-Hao, Lu Chang-Hsien, Hsu Cheng-Ming, Lai Chia-Hsuan, Liao Chun-Ta, Kang Chung-Jan, Tsai Yuan-Hsiung, Tsai Ming-Shao, Huang Ethan I, Chang Geng-He, Ko Chien-An, Tsai Ming-Hsien, Tsai Yao-Te
Department of Nuclear Medicine, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
College of Medicine, Chang Gung University, Taoyuan 330036, Taiwan.
Biomedicines. 2023 Jul 11;11(7):1954. doi: 10.3390/biomedicines11071954.
We investigated the prognostic utility of preoperative neck lymph node-to-primary tumor maximum standardized uptake value ratios (NTRs) in oral cavity squamous cell carcinoma (OSCC). We retrospectively reviewed the medical records of 141 consecutive patients who were diagnosed as having OSCC and had received fluorodeoxyglucose-positron emission tomography within 2 weeks prior to radical surgery between 2009 and 2018. To determine the optimal NTR cutoff, receiver operating characteristic analysis for overall survival (OS) was executed. The NTR's prognostic value for disease-free survival (DFS) and OS were determined through Cox proportional hazards analysis and the Kaplan-Meier method. We determined the median (range) follow-up duration to be 35.2 (2.1-122.4) months. The optimal NTR cutoff was 0.273, and patients with a higher NTR (≥0.273) exhibited significantly worse DFS and OS ( = 0.010 and 0.003, respectively). A higher NTR (≥0.273) predicted poorer DFS (hazard ratio: 2.696, = 0.008) and OS (hazard ratio: 4.865, = 0.003) in multivariable analysis. We created a nomogram on the basis of the NTR, and it could accurately predict OS (concordance index: 0.774). Preoperative NTRs may be a useful prognostic biomarker for DFS and OS in patients with OSCC who have undergone surgery. NTR-based nomograms may also be helpful prognostic tools in clinical trials.
我们研究了术前颈部淋巴结与原发肿瘤最大标准化摄取值比值(NTRs)在口腔鳞状细胞癌(OSCC)中的预后价值。我们回顾性分析了2009年至2018年间141例连续诊断为OSCC且在根治性手术前2周内接受氟脱氧葡萄糖正电子发射断层扫描的患者的病历。为确定最佳NTR临界值,进行了总生存(OS)的受试者工作特征分析。通过Cox比例风险分析和Kaplan-Meier法确定NTR对无病生存(DFS)和OS的预后价值。我们确定中位(范围)随访时间为35.2(2.1 - 122.4)个月。最佳NTR临界值为0.273,NTR较高(≥0.273)的患者DFS和OS明显更差(分别为P = 0.010和0.003)。在多变量分析中,较高的NTR(≥0.273)预示着较差的DFS(风险比:2.696,P = 0.008)和OS(风险比:4.865,P = 0.003)。我们基于NTR创建了一个列线图,它可以准确预测OS(一致性指数:0.774)。术前NTRs可能是接受手术的OSCC患者DFS和OS的有用预后生物标志物。基于NTR的列线图在临床试验中也可能是有用的预后工具。